Tarabios is a health technology startup that originated from Koc University's Optic Mems Laboratory. The company is in the process of developing a point-of-care (POC) blood diagnostic device intended for home use. This device is designed to monitor blood clot times, particularly for patients undergoing Warfarin Therapy, a common treatment for blood clots.

The technology behind this device is proprietary and its intellectual property rights are protected. The company's business model revolves around the development and sale of these mobile devices. Tarabios aims to make blood testing more accessible and convenient, reducing the need for patients to visit medical facilities for routine blood tests.

In the future, Tarabios plans to expand the capabilities of its platform technology to include tests for cardiac markers, sexually transmitted diseases, hepatitis, tuberculosis, and other infectious diseases. This expansion would broaden the company's market and potential client base.

Tarabios has already garnered attention and recognition in the medical technology field. The company was selected to present its technology at the VPDP event in Ankara, Turkey, where it received high regards from the investment committee and TUBITAK. The team also attended the 24th MedTech Investing Europe Conference in Lausanne, Switzerland, where they presented their technology to potential investors.

Keywords: Health Technology, Point-of-Care Testing, Blood Diagnostic Device, Home Use, Warfarin Therapy, Cardiac Markers, Sexually Transmitted Diseases, Hepatitis, Tuberculosis, Infectious Diseases.